Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Innovative Evaporator Technology Protects Samples & Increases Productivity

Published: Wednesday, November 07, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
Proprietary SampleGuard™ temperature control technology on Genevac HT Series II Evaporators enables them to automatically detect when samples are dry and then shut down - safeguarding valuable samples from potential thermal degradation.

genevacpr213-image.gif

Combined with Genevac's continuous running condensers, SampleGuard™ allows easy unattended operation offering the possibility of significant increases in productivity through use of overnight evaporation runs.

 Comprising two thermocouples and a unique sample temperature radio transmitter, SampleGuard™ provides real time feedback enabling unmatched accuracy in controlling of actual sample temperatures. SampleGuard™ probes can measure temperature at any point in the sample holder. Either one or two probes can be used to accurately and reliably determine end-of-run, enabling the system to be easily set for optimal performance and automatic shutdown. 

HT Series II Solvent Evaporators offer leading edge features that provide superior sample protection, flexibility for multiple applications, consistency of results, robust build quality, ease-of-use, rapid high-throughput results and low maintenance.

For further information please contact Genevac on telephone +44-1473-240000 / +1-845-255-5000 or email salesinfo@genevac.co.uk.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Consolidate Evaporator & Freeze Dryer Sales Channels in the UK
Company appoints BioPharma Process Systems as exclusive UK distributor.
Thursday, May 15, 2014
GenVec Announces Manufacturing Agreement for TNFerade™
The agreement will cover technology transfer, scale-up, and validation of the manufacturing process for TNFerade through cGMP consistency lots.
Friday, January 25, 2008
Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac Ltd. Acquired by Riverlake Partners
The acquisition of Genevac from Thermo Scientific will play a critical role in Riverlake's SP Industries for future growth and expansion.
Friday, April 13, 2007
New Approach to Compound Library Maintenance
The report describes a new high throughput process to produce compound libraries as dry films that have been validated for long-term storage.
Thursday, April 06, 2006
Genevac Moves on WEEE Compliance
As a result of upgrade and trade-in schemes over the last year, Genevac took back and has recycled 150 evaporators.
Tuesday, March 21, 2006
High-throughput Evaporation of Strongly Acidic Chemicals
The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.
Thursday, July 14, 2005
Genevac DD- 4 & Metz Syn10 on Display at Labautomation 2002

Monday, January 14, 2002
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!